This innovative drug works by mimicking two naturally occurring hormones, GLP-1 and GIP, which help regulate blood sugar levels and appetite
GLP-1-derived nonapeptide GLP-1(28-36) amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice
Wegovy, Ozempic, Mounjaro, and Zepbound are registered trademarks of their respective owners
While Ozempic is officially FDA-approved for type 2 diabetes, many healthcare providers prescribe it off-label to help patients lose weight
55 In regard to their safety profile, small molecule GLP-1 RAs have also shown similar side effects, being the gastrointestinal symptoms such as nausea, vomiting, and diarrhea the most commonly presented